These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 104621)

  • 21. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
    Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
    Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythrocyte antigens on human platelets. Absence of Rh, Duffy, Kell, Kidd, and Lutheran antigens.
    Dunstan RA; Simpson MB; Rosse WF
    Transfusion; 1984; 24(3):243-6. PubMed ID: 6427991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients.
    Floch A; Gien D; Tournamille C; Chami B; Habibi A; Galactéros F; Bierling P; Djoudi R; Pondarré C; Peyrard T; Pirenne F
    Transfusion; 2018 Jun; 58(6):1527-1535. PubMed ID: 29707783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mimicking red blood cell autoantibody accompanying transfusion and alloimmunization.
    Wenz B; Gurtlinger K; Wheaton D; Dugan EP
    Transfusion; 1982; 22(2):147-50. PubMed ID: 6803409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Null types of the human erythrocyte blood groups. Philip Levine award lecture.
    Allen FH
    Am J Clin Pathol; 1976 Sep; 66(3):467-74. PubMed ID: 822706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
    Karafin MS; Westlake M; Hauser RG; Tormey CA; Norris PJ; Roubinian NH; Wu Y; Triulzi DJ; Kleinman S; Hendrickson JE;
    Br J Haematol; 2018 Jun; 181(5):672-681. PubMed ID: 29675950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extravascular hemolytic transfusion reactions due to anti-Yk(a)+Cs(a).
    Molthan L; Wick RW; Gross BM
    Rev Fr Transfus Immunohematol; 1981 Jun; 24(3):263-71. PubMed ID: 6792683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of eight blood-group systems and ABH secretion in Mongolian, Korean, and Zhuang nationalities in China.
    Yuan YD; Du RF; Chen LZ; Xu JJ; Cui MY; Wang YF; Li SZ; Goedde HW; Benkmann HG; Kriese L
    Ann Hum Biol; 1984; 11(5):377-88. PubMed ID: 6435501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
    Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K
    Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed hemolytic transfusion reactions.
    Vogel RA; Worthington M
    JAMA; 1978 Nov; 240(22):2432-3. PubMed ID: 101679
    [No Abstract]   [Full Text] [Related]  

  • 33. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.
    Fasano RM; Chou ST
    Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further study of Rh, Kell, Duffy, P, MN, Lewis and Gerbiech blood groups of the Thais.
    Chandanayingyong D; Bejrachandra S; Metaseta P; Pongsataporn S
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):209-11. PubMed ID: 118532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemolytic disease of the newborn caused by maternal allo-immunization against erythrocyte antigens other than A, B and rhesus D].
    Monestier M; Rigal D; Juron-Dupraz F; Meyer F
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):671-80. PubMed ID: 6520354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program.
    Vege S; Westhoff CM
    Immunohematology; 2006; 22(3):143-7. PubMed ID: 17105364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative immunoferritin microscopy of Fya, Fyb, Jka, U, and Dib antigen site numbers on human red cells.
    Masouredis SP; Sudora E; Mahan L; Victoria EJ
    Blood; 1980 Dec; 56(6):969-77. PubMed ID: 6777001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study.
    Sirchia G; Zanella A; Parravicini A; Morelati F; Rebulla P; Masera G
    Transfusion; 1985; 25(2):110-2. PubMed ID: 3920790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
    Ameen R; Al Shemmari S; Al-Bashir A
    Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.
    Azarkeivan A; Ansari S; Ahmadi MH; Hajibeigy B; Maghsudlu M; Nasizadeh S; Shaigan M; Toolabi A; Salahmand M
    Pediatr Hematol Oncol; 2011 Sep; 28(6):479-85. PubMed ID: 21854216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.